The Diary Of A CEO
David Sinclair: Can Aging Be Reversed? After 8 Weeks, Cells Appeared 75% Younger In Tests!
with David Sinclair
23 Mar 2026
18 min read
2h 15m
TL;DR
David Sinclair reveals his lab has successfully reversed cellular aging by 75% in tests, with human trials beginning in 2026. He argues aging is not inevitable biological wear but an 'identity crisis' of cells—a loss of epigenetic information that can be restored, like reinstalling software. If successful, this could lead to medicines within 10 years that periodically reset the body's age, potentially extending human lifespan dramatically or even achieving biological immortality within this century.
David Sinclair is a Harvard professor who has spent 30 years studying aging, longevity, and age reversal. His lab has developed technology that reverses the aging of cells and tissues in animals by approximately 75%, with the first human trials testing blindness treatment expected in 2026. He is the author of 'Lifespan' and believes we are at a turning point in human history where aging can be controlled, potentially extended lifespans by decades or more.
Takeaways
1
Aging is epigenetic corruption, not wear Sinclair's information theory posits aging results from loss of epigenetic control—the chemical labels (methylation) on DNA that tell cells which genes to activate. When cells experience stress like broken chromosomes, they strip these labels to survive, but don't fully reset them afterward. This accumulated miscommunication causes cells to lose identity (skin cells start acting like nerve cells), driving disease and decline—but it's theoretically reversible by reinstalling the original epigenetic 'software.'
2
Three genes can reset cellular age 75% Sinclair's team identified three specific genes that, when activated for 6-8 weeks, reverse cell aging by approximately 75% in both animal and human tissue cultures without causing cancer or further degradation. The breakthrough works across multiple tissue types (retina, skin, neurons, muscle), suggesting a universal rejuvenation mechanism. The first human trial will test this on blindness patients in 2026, with plans to eventually deliver the therapy as an oral compound rather than gene therapy.
3
Longevity pill possible within 10 years Sinclair predicts a drinkable rejuvenation treatment could exist within a decade based on current lab progress. His team has already demonstrated multi-week cellular rejuvenation in mice using oral compounds, and extended lifespan by 100% (adding ~10 years to a 70-year-old's remaining life) in aged mice. If replicated in humans, this would shift medicine from treating individual diseases to periodically resetting the entire organism's biological age, potentially enabling continuous life extension if the treatment can be repeated safely.